Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study
Mariam M. Fakhry, Amr A. Mattar, Marwa Alsulaimany, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7455-7455
Open Access | Times Cited: 10

Showing 10 citing articles:

Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, in vitro and multiscale molecular modeling approaches
Siwar Ghannay, Budur Saleh Aldhafeeri, Iqrar Ahmad, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25911-e25911
Open Access | Times Cited: 6
Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis
R. R. Joshi, Harsh Gaikwad, Bhavana Soge, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles
Mahmoud S. Elkotamy, Mohamed K. Elgohary, Islam A. Elkelesh, et al.
Bioorganic Chemistry (2025), pp. 108247-108247
Closed Access
Design, Synthesis and Biological Assessment of N′-(2-Oxoindolin-3-ylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazides as Potential Anti-Proliferative Agents toward MCF-7 Breast Cancer
Najla A. Alshaye, Mohamed K. Elgohary, Mahmoud S. Elkotamy, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 216-216
Open Access | Times Cited: 5
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
Molecular docking, DFT and antiproliferative properties of 4‐(3,4‐dimethoxyphenyl)−3‐(4‐methoxyphenyl)−1‐phenyl‐1H‐pyrazolo[3,4‐b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency
Faizah A. Binjubair, Basma S. Almansour, Noha I. Ziedan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 1
Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition
Osama Abdulaziz, Farhan R. Khan, Nahed S. Alharthi, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access
İMİDAZOPİRİDİN TÜREVLERİNİN KANSER HÜCRE SİNYALİNDEKİ ETKİLERİ
Hazal Ceylan, Erkan Yurtçu
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi (2024) Vol. 26, Iss. 2, pp. 245-251
Open Access
Molecular Docking, Synthesis and Biological Evaluation of New Benzimidazole‐Pyridine Derivatives as Potential Aromatase Inhibitor for the Treatment of Cancer
Prafulla Sabale, Nusrat Sayyad, Vidya Sabale, et al.
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access
Insight into the therapeutic potential of pyrazole‐thiazole hybrids: A comprehensive review
Garima Sumran, Manisha Sharma, Ranjana Aggarwal
Archiv der Pharmazie (2024)
Closed Access
Page 1

Scroll to top